Last reviewed · How we verify

NCT07281729

Investigation on Risk Factors for Suicide Among Chinese Patients With Mood Disorders

ENROLLING BY INVITATION Last updated 15 December 2025
What this trial tests

trial in Bipolar Disorder;Major Depressive Disorder;Mood Disorders in 25,000 participants. Enrolling by invitation.

Timeline
1 August 2025
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorShanghai Mental Health Center
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment25,000
Start date1 August 2025
Primary completion30 June 2026
Estimated completion30 June 2026
Sites2 locations across China

Conditions studied

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

Adults 16 to 60, any sex, with Bipolar Disorder;Major Depressive Disorder;Mood Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main research objective: Through questionnaire surveys, obtain the occurrence levels of self-harm/suicide behaviors, the status of acquired suicidal ability, and their correlations with self-harm/suicide behaviors among patients with mood disorders in mental specialty hospitals and general hospitals. Main research purpose: (1) Conduct a comprehensive assessment and analysis of the occurrence of suicide/self-harm behaviors, the level of acquired suicidal ability, and their distribution among patients with mood disorders in China; (2) Compare the characteristics and acquired suicidal ability status of patients with mood disorders in mental specialty hospitals and general hospitals' psychological outpatient departments regarding suicide/self-harm behaviors; (3) From multiple dimensions, explore the influencing factors of self-harm/suicide behaviors and acquired suicidal ability in patients with mood disorders, form a list of suicide risk factors and clarify the key risk factors, establish a predictive model for acquired suicidal ability; (4) Through follow-up on whether patients have another occurrence of suicide behavior, clarify the impact of key risk factors on the occurrence of suicide behavior, and verify the effectiveness of the predictive model for acquired suicidal ability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07281729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing